Back to top

$LYEL stock is up 11% today. Here's what we see in our data.

$LYEL stock has now risen 11% today, according to our price data from Polygon. There has been approximately $2,927,185 of trading volume.

Here is what we see in our data on $LYEL (you can track the company live on Quiver's $LYEL stock page):

$LYEL Insider Trading Activity

LYEL Insider Trades

$LYEL insiders have traded $LYEL stock on the open market 13 times in the past 6 months. Of those trades, 2 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $LYEL stock by insiders over the last 6 months:

  • VENTURE PARTNERS IX, LLC ARCH purchased 488,090 shares for an estimated $12,499,984
  • VENTURE FUND XIII, L.P. ARCH purchased 488,090 shares for an estimated $12,499,984
  • DAVID SHOOK (Chief Medical Officer) sold 1,977 shares for an estimated $24,989
  • VERONICA SANCHEZ BULIS (VP, Corporate Controller) has made 0 purchases and 2 sales selling 838 shares for an estimated $13,008.
  • LYNN SEELY (President and CEO) has made 0 purchases and 2 sales selling 778 shares for an estimated $12,929.
  • GARY K. LEE (Chief Scientific Officer) has made 0 purchases and 2 sales selling 261 shares for an estimated $4,338.
  • STEPHEN J. HILL (Chief Operating Officer) has made 0 purchases and 2 sales selling 178 shares for an estimated $2,960.
  • CELLULAR THERAPEUTICS HOLDINGS LTD INNOVATIVE has made 0 purchases and 2 sales selling 20 shares for an estimated $274.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$LYEL Hedge Fund Activity

We have seen 49 institutional investors add shares of $LYEL stock to their portfolio, and 34 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive LYEL Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$LYEL Revenue

LYEL Quarterly Revenue

$LYEL had revenues of $4K in Q2 2026. This is a decrease of -50.0% from the same period in the prior year.

You can track LYEL financials on Quiver Quantitative's LYEL stock page.

You can access data on LYEL stock through the Quiver Quantitative API.

$LYEL Price Targets

Multiple analysts have issued price targets for $LYEL recently. We have seen 3 analysts offer price targets for $LYEL in the last 6 months, with a median target of $44.0.

Here are some recent targets:

  • Gil Blum from Needham set a target price of $44.0 on 06/15/2026
  • Reni J. Benjamin from Citizens set a target price of $34.0 on 06/15/2026
  • Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $45.0 on 06/09/2026

You can track data on $LYEL on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lyell Immunopharma, Inc. (LYEL)